MX380684B - Combinaciones de lisobactina y aminoglucosidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos. - Google Patents

Combinaciones de lisobactina y aminoglucosidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos.

Info

Publication number
MX380684B
MX380684B MX2019009573A MX2019009573A MX380684B MX 380684 B MX380684 B MX 380684B MX 2019009573 A MX2019009573 A MX 2019009573A MX 2019009573 A MX2019009573 A MX 2019009573A MX 380684 B MX380684 B MX 380684B
Authority
MX
Mexico
Prior art keywords
gram
human animals
lysobactin
positive
negative bacteria
Prior art date
Application number
MX2019009573A
Other languages
English (en)
Other versions
MX2019009573A (es
Inventor
Gert Daube
Guido Schiffer
Johannes Köbberling
Stefan Fälker
Wolfgang Wiehl
Original Assignee
Elanco Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Animal Health Gmbh filed Critical Elanco Animal Health Gmbh
Publication of MX2019009573A publication Critical patent/MX2019009573A/es
Publication of MX380684B publication Critical patent/MX380684B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a la combinación de lisobactina con un antibiótico aminoglucósido para su uso en el tratamiento de enfermedades causadas por bacterias gram positivas y Gram negativas en animales no humanos. Se ha comprobado que la invención es particularmente útil con relación al tratamiento de mastitis en animales no humanos. Particularmente la presente invención puede tratar la mastitis bovina.
MX2019009573A 2017-02-17 2018-02-14 Combinaciones de lisobactina y aminoglucosidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos. MX380684B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17156737.3A EP3363452A1 (en) 2017-02-17 2017-02-17 Combinations of lysobactin and aminogylcosides against diseases caused by gram-positive and gram-negative bacteria in non-human animals
PCT/EP2018/053667 WO2018149871A1 (en) 2017-02-17 2018-02-14 Combinations of lysobactin and aminoglycosides against diseases caused by gram-positive and gram-negative bacteria in non-human animals

Publications (2)

Publication Number Publication Date
MX2019009573A MX2019009573A (es) 2019-10-02
MX380684B true MX380684B (es) 2025-03-12

Family

ID=58098497

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019009573A MX380684B (es) 2017-02-17 2018-02-14 Combinaciones de lisobactina y aminoglucosidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos.

Country Status (16)

Country Link
US (2) US20200230204A1 (es)
EP (2) EP3363452A1 (es)
JP (1) JP6655771B1 (es)
KR (1) KR102123599B1 (es)
CN (2) CN121987761A (es)
AR (1) AR111569A1 (es)
AU (1) AU2018222615B2 (es)
BR (1) BR112019017010A2 (es)
CA (1) CA3053608C (es)
ES (1) ES2893927T3 (es)
MX (1) MX380684B (es)
NZ (1) NZ755710A (es)
RU (1) RU2760008C2 (es)
TW (1) TWI783969B (es)
UY (1) UY37607A (es)
WO (1) WO2018149871A1 (es)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
US4172138A (en) * 1977-03-23 1979-10-23 Rhodes Russell E Method and composition of matter for the treatment of dry cows for mastitis
CA1266247A (en) 1985-03-25 1990-02-27 Adrienne A. Tymiak Antibiotic prepared from lysobacter sp. sc 14,067
JPH01132600A (ja) 1987-11-17 1989-05-25 Shionogi & Co Ltd カタノシンａおよびｂならびにその製造法
DE10320781A1 (de) 2003-05-09 2004-11-25 Bayer Healthcare Ag Acylierte Nonadepsipeptide
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
DE102004051024A1 (de) 2004-10-20 2006-04-27 Bayer Healthcare Ag Heterocyclyl-substituierte Nonadepsipeptide
DE102004051023A1 (de) * 2004-10-20 2006-05-04 Bayer Healthcare Ag Desoxo-Nonadepsipeptide
DE102004051025A1 (de) 2004-10-20 2006-04-27 Bayer Healthcare Ag Substituierte Nonadepsipeptide
DE102004053409A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Verfahren zur gezielten Herstellung von Lysobactinfragmenten
DE102004053410A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Cyclische Nonadepsipeptidamide
DE102004053407A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Acylierte Nonadepsipeptide II
DE102006003443A1 (de) 2006-01-25 2007-07-26 Aicuris Gmbh & Co. Kg Asparagin-10-substituierte Nonadepsipeptide
DE102006018080A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Lysobactinamide
DE102006018250A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Verfahren zum Herstellen von cyclischen Depsipeptiden
ES2882063T3 (es) * 2012-12-03 2021-12-01 Novobiotic Pharmaceuticals Llc Nuevo depsipéptido y usos del mismo

Also Published As

Publication number Publication date
BR112019017010A2 (pt) 2020-04-14
AU2018222615B2 (en) 2020-07-23
ES2893927T3 (es) 2022-02-10
KR102123599B1 (ko) 2020-06-16
NZ755710A (en) 2022-04-29
KR20190097293A (ko) 2019-08-20
CN121987761A (zh) 2026-05-08
CN110234338A (zh) 2019-09-13
EP3548059B1 (en) 2021-07-21
TWI783969B (zh) 2022-11-21
RU2019129026A (ru) 2021-03-17
AU2018222615A1 (en) 2019-08-08
US20200230204A1 (en) 2020-07-23
MX2019009573A (es) 2019-10-02
RU2760008C2 (ru) 2021-11-22
EP3548059A1 (en) 2019-10-09
CA3053608A1 (en) 2018-08-23
US20220000969A1 (en) 2022-01-06
AR111569A1 (es) 2019-07-31
TW201834662A (zh) 2018-10-01
JP6655771B1 (ja) 2020-02-26
WO2018149871A1 (en) 2018-08-23
RU2019129026A3 (es) 2021-03-17
UY37607A (es) 2018-09-28
EP3363452A1 (en) 2018-08-22
JP2020508299A (ja) 2020-03-19
CA3053608C (en) 2020-09-15

Similar Documents

Publication Publication Date Title
MX2022006525A (es) Activo de polipeptidos de lisina contra bacterias gram-negativas.
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
PH12019500360A1 (en) Antibiotic compounds
MX389625B (es) Prueba de susceptibilidad antimicrobiana e identificacion de bacterias.
CL2015003120A1 (es) Cepas bacterianas que poseen actividad antimicrobiana y composiciones de control biológico que las contienen
MY179292A (en) Monobactam organic compounds for the treatment of bacterial infections
MX2016009898A (es) Tratamientos para acne resistente.
PE20191356A1 (es) Suministro de proteinas basado en bacterias con virulencia atenuada
PH12015502216A1 (en) Compositions and methods for improving the health of aquatic animals
BR112013000097A2 (pt) composições e métodos relacionados a variantes da proteína a (spa)
ECSP20084373A (es) Tiofencarboxamidas sustituidas y análogos de las mismas
NZ728429A (en) Acinetobacter lysins
MX376475B (es) Derivado de polimixina y usos del mismo.
WO2016108930A3 (en) Antisense antibacterial compounds and methods
CO2017010271A2 (es) Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición
MX2016010385A (es) Agentes antibacterianos.
BR112012024999A2 (pt) combinação e uso
BR112018009753A8 (pt) bactérias de virulência atenuada para o tratamento de tumores sólidos malignos
MX2015015127A (es) Enzimas para alimentacion animal.
PH12016501532A1 (en) Antibacterial combinations comprising polymyxin
WO2019035089A3 (en) Lectin-bound bacteria and uses thereof
PH12014501239A1 (en) Thymol and totarol antibacterial composition
MX2019009573A (es) Combinaciones de lisobactina y aminoglucosidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos.
MX2023012943A (es) Compuesto antibacteriano.
AR084421A1 (es) Betametasona como agente antibacteriano